Why the study?
Does sheng-mai-san (SMS) prevent adriamycin-induced cardiomyopathy in Wistar rats?
Does sheng-mai-san (SMS) prevent adriamycin-induced cardiomyopathy in Wistar rats?
Sheng-mai-san (SMS) demonstrates protective effects against adriamycin-induced cardiomyopathy in a rat model by reducing oxidative stress and preserving myocardial ultrastructure.
No takes yet. Share an insight, caveat, or question.
Hypothesis-generating for SMS in anthracycline cardiotoxicity; does not support clinical use without human trials.
You et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: